1. Mendoza, N., et al. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecol Endocrinol. 2019; 35 (8): 695–700.
2. SEF. COMMUNITY HEALTH WHITE PAPER: “Infertility in Spain: Current Situation and Perspectives”. [Internet] Available at: https://www.sefertilidad.net/docs/biblioteca/libros/libroBlanco.pdf.
3. Silber, S. J., Kato, K., Aoyama, N., et al. Intrinsic fertility of human oocytes. Fertile Steril. 2017; 107 (5): 1232–1237.
4. Sasaki, H., Hamatani, T., Kamijo, S., et al. Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence. Front Endocrinol (Lausanne). 2019; 10: 811. Published 2019 Nov 22.
5. Finkel, T., Holbrook, N. J. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408 (6809): 239–247.
6. Lan, L., Harrison, C. L., Misso, M., et al. Systematic review and meta-analysis of the impact of preconception lifestyle interventions on fertility, obstetric, fetal, anthropometric and metabolic outcomes in men and women. Hum Reprod. 2017; 32 (9): 1925–1940.
7. Ginsburg, E. S., Racowsky, C. In vitro fertilization. Current opinion in obstetrics & gynecology. 1990; 2 5, 754–61.
8. Kousta, E., Tolis, G., Franks, S. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. Hormones (Athens). 2005; 4 (3): 133–147.
9. Costello, M. F., Misso, M. L., Balen, A., et al. Evidence summaries and recommendations from the international evidence based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Hum Reprod Open. 2019; 2019 (1): hoy021. Published 2019 Jan 4.
10. Rady, H. A. Maternal methyltetrahydrofolate reductase gene mutation in patients with missed abortions. J Taibah Univ Med Sc 2018; 13 (1): 93e96.HA Rady96.
11. Gonzalez-Porras, J. R., Perez-Lopez, E. Alberca, I., Lozano, F. S. Influence of the C677T mutation of the methylenetetrahydrofolate reductase gene in venous thromboembolic disease. Angiology. 2010 ISSN: 0003–3170, Vol: 62, Issue: 6, Page: 225–231.
12. Chaithra, P. T., Malini, S. S. & Kumar, C. S. (2011). An Overview of Genetic and Molecular Factors Responsible for Recurrent Pregnancy Loss. International Journal of Human Genetics, 11 (4), 217–225.
13. Clement, P. 5-Methyltetrahydrofolate reduces blood homocysteine level significantly in C677T methyltetrahydrofolate reductase single-nucleotide polymorphism carriers consulting for infertility. J Gynecol Obstet Hum Reprod. 2020; 49 (1): 101622.
14. Govindaiah, V., Naushad, S. M., Prabhakara, K., Krishna, P. C. & Radha Rama Devi, A. (2009). Association of parental hyperhomocysteinemia and C677T Methylene tetrahydrofolate reductase (MTHFR) polymorphism with recurrent pregnancy loss. Clinical Biochemistry, 42 (4–5), 380–386.
15. Chavarro, J. E., Schlaff, W. D. Introduction: Impact of nutrition on reproduction: an overview. Fertile Steril. 2018; 110 (4): 557–559.
16. Mendoza, N., et al. “High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.” Gynecol Endocrinol. 2020, 36,5: 398–401.
17. Abedini, M., et al. The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial. Phytother Res. 2021 Jan; 35 (1): 442–14.
18. Fernando, S., et al. Melatonin: shedding light on infertility?. A review of the recent literature. J Ovarian Res. 2014 Oct 21; 7: 98.
19. Espino, J., et al. Impact of Melatonin Supplementation in Women with Unexplained Infertility Undergoing Fertility Treatment. Antioxidants (Basel). 2019 Aug 23; 8 (9): 338.
20. Li, Y., et al. “Melatonin promotes human oocyte maturation and early embryo development by enhancing clathrin-mediated endocytosis.” Journal of pineal research vol. 67, 3 (2019): e12601.
21. Bahadori, M., et al. “Level of Vitamin E in Follicular Fluid and Serum and Oocyte Morphology and Embryo Quality in Patients Undergoing IVF Treatment.” Journal of family & reproductive health vol. 11, 2 (2017): 74–81.
